Search results summary
From Health Canada
Search criteria
- Status: Select all
- AIG: 0108704001
Search results
Status | DIN | Company | Product | Class | PM See footnote1 | Schedule | # See footnote2 | A.I. name See footnote3 | Strength |
---|---|---|---|---|---|---|---|---|---|
Cancelled Post Market | 02248127 | BIOMED PHARMA | BIO-FLURAZEPAM | Human | Yes | Targeted (CDSA IV) | 1 | FLURAZEPAM HYDROCHLORIDE | 30 MG |
Cancelled Post Market | 00012718 | VALEANT CANADA LP / VALEANT CANADA S.E.C. | DALMANE | Human | Yes | Targeted (CDSA IV) | 1 | FLURAZEPAM HYDROCHLORIDE | 30 MG |
Marketed | 00521701 | AA PHARMA INC | FLURAZEPAM | Human | Yes | Targeted (CDSA IV) | 1 | FLURAZEPAM HYDROCHLORIDE | 30 MG |
Cancelled Post Market | 00578487 | PRO DOC LIMITEE | FLURAZEPAM 30 | Human | Yes | Targeted (CDSA IV) | 1 | FLURAZEPAM HYDROCHLORIDE | 30 MG |
Cancelled Pre Market | 02232657 | LABORATOIRES CONFAB INC | FLURAZEPAM 30MG CAPSULE | Human | No | Targeted (CDSA IV) | 1 | FLURAZEPAM HYDROCHLORIDE | 30 MG / CAP |
Cancelled Post Market | 00496553 | NOVOPHARM LIMITED | NOVO-FLUPAM CAP 30MG | Human | No | Targeted (CDSA IV) | 1 | FLURAZEPAM HYDROCHLORIDE | 30 MG |
Cancelled Post Market | 00667099 | PHARMASCIENCE INC | PMS-FLURAZEPAM CAP 30MG | Human | No | Targeted (CDSA IV) | 1 | FLURAZEPAM HYDROCHLORIDE | 30 MG / CAP |
Cancelled Post Market | 02241282 | LABORATOIRE RIVA INC. | RIVA-FLURAZEPAM 30MG CAPSULES | Human | No | Targeted (CDSA IV) | 1 | FLURAZEPAM HYDROCHLORIDE | 30 MG / CAP |
Dormant | 00414239 | BIOMED PHARMA | SOM-PAM | Human | Yes | Targeted (CDSA IV) | 1 | FLURAZEPAM HYDROCHLORIDE | 30 MG |
Cancelled Post Market | 00483818 | AXXESS PHARMA INC. | SOMNOL 30MG | Human | No | Targeted (CDSA IV) | 1 | FLURAZEPAM HYDROCHLORIDE | 30 MG |
Application information
Related information
Contact us
Version 4.0.3